OOIR: Observatory of International Research

Papers

(The H4-Index of Current Neuropharmacology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	153
Role of Glycerophospholipid Metabolism in Epilepsy	133
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	112
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	111
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	102
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	95
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	82
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	81
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	78
The Role of Natural Products in Treatment of Depressive Disorder	75
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	72
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	67
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	66
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	64
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	61
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	54
Meet the Editorial Board Member	53
Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor	51
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	51
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	51
Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	50
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	50
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	50
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	45
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	45

Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	45
Myeloid-derived Suppressor Cells and Multiple Sclerosis	43
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	43
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	42
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	42
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies	41
What is the Role of Lithium in Epilepsy?	40
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	40
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	39
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression	38
Antioxidants, Hormetic Nutrition, and Autism	38
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment	37
Meet the Country Editor	37
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data	37